The expression of CCL2 by T lymphocytes of mammary tumor bearers: Role of tumor-derived factors

Cellular Immunology

Volumn 235, Issue 2, 2005, Pages 122-135

  Owen, Jennifer L ^a   Lopez, Diana M ^b,c   Grosso, Joseph F ^d   Guthrie, Kathleen M ^a   Herbert, Lynn M ^b   Torroella Kouri, Marta ^b   Iragavarapu Charyulu, Vijaya ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CCL2; Chemokines; GM CSF; IFN ; Mammary tumor; PS; T lymphocytes

Indexed keywords

DIMETHYLBENZ[A]ANTHRACENE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLSERINE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELLS, CULTURED; CHEMOKINE CCL2; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; PHOSPHATIDYLSERINES; T-LYMPHOCYTES;

ANIMALIA;

EID: 27744499202     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.08.032     Document Type: Article

References (57)

1. B. Homey, A. Muller, and A. Zlotnik Chemokines: agents for the immunotherapy of cancer? Nat. Rev. Immunol. 2 2002 175 184
2. A. Zlotnik, and O. Yoshie Chemokines: a new classification system and their role in immunity Immunity 12 2000 121 127
3. D. Rossi, and A. Zlotnik The biology of chemokines and their receptors Annu. Rev. Immunol. 18 2000 217 242
4. B.J. Rollin Chemokines Blood 90 1997 909 928
5. K. Matsushima, C.G. Larsen, G.C. DuBois, and J.J. Oppenheim Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line J. Exp. Med. 169 1989 1485 1490
6. M.W. Carr, S.J. Roth, E. Luther, S.S. Rose, and T.A. Springer Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant Proc. Natl. Acad. Sci. USA 91 1994 3652 3656
7. P. Allavena, G. Bianchi, D. Zhou, J. van Damme, P. Jilek, S. Sozzani, and A. Mantovani Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3 Eur. J. Immunol. 24 1994 3233 3236
8. P. Kuna, S.R. Reddigari, D. Rucinski, J.J. Oppenheim, and A.P. Kaplan Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils J. Exp. Med. 175 1992 489 493
9. R. Horuk Chemokine receptors Cytokine Growth Factor Rev. 12 2001 313 335
10. S.D. Cushing, J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab, F. Parhami, R. Gerrity, C.J. Schwartz, and A.M. Fogelman Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells Proc. Natl. Acad Sci. USA 87 1990 5134 5138
11. A.E. Koch, S.L. Kunkel, L.A. Harlow, B. Johnson, H.L. Evanoff, G.K. Haines, M.D. Burdick, R.M. Pope, and R.M. Strieter Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis J. Clin. Invest. 90 1992 772 779
12. A.R. Sousa, S.J. Lane, J.A. Nakhosteen, T. Yoshimura, T.H. Lee, and R.N. Poston Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects Am. J. Respir. Cell. Mol. Biol. 10 1994 142 147
13. C. McManus, J.W. Berman, F.M. Brett, H. Staunton, M. Farrell, and C.F. Brosnan MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study J. Neuroimmunol. 86 1998 20 29
14. D.T. Graves, R. Barnhill, T. Galanopoulos, and H.N. Antoniades Expression of monocyte chemotactic protein-1 in human melanoma in vivo Am. J. Pathol. 140 1992 9 14
15. J. Kuratsu, K. Yoshizato, T. Yoshimura, E.J. Leonard, H. Takeshima, and Y. Ushio Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma J. Natl. Cancer Inst. 85 1993 1836 1839
16. F.L. Sciacca, M. Sturzl, F. Bussolino, M. Sironi, H. Brandstetter, C. Zietz, D. Zhou, C. Matteucci, G. Peri, and S. Sozzani Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells J. Immunol. 153 1994 4816 4825
17. R.P. Negus, G.W. Stamp, M.G. Relf, F. Burke, S.T. Malik, S. Bernasconi, P. Allavena, S. Sozzani, A. Mantovani, and F.R. Balkwill The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer J. Clin. Invest. 95 1995 2391 2396
18. B. Amann, F.G. Perabo, A. Wirger, H. Hugenschmidt, and W. Schultze-Seemann Urinary levels of monocyte chemo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer Br. J. Urol. 82 1998 118 121
19. T. Valkovic, K. Lucin, M. Krstulja, R. Dobi-Babic, and N. Jonjic Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer Pathol. Res. Pract. 194 1998 335 340
20. L. Hefler, C. Tempfer, G. Heinze, K. Mayerhofer, G. Breitenecker, S. Leodolter, A. Reinthaller, and C. Kainz Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients Br. J. Cancer 81 1999 855 859
21. R. Salcedo, M.L. Ponce, H.A. Young, K. Wasserman, J.M. Ward, H.K. Kleinman, J.J. Oppenheim, and W.J. Murphy Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Blood 96 2000 34 40
22. V. Goede, L. Brogelli, M. Ziche, and H.G. Augustin Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1 Int. J. Cancer 82 1999 765 770
23. L. Peng, S. Shu, and J.C. Krauss Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells Cancer Res. 57 1997 4849 4854
24. D.M. Lopez, M.E. Handel-Fernandez, X. Cheng, V. Charyulu, L.M. Herbert, M.R. DiNapoli, and C.L. Calderon Cytokine production by lymphoreticular cells from mammary tumor bearing mice: the role of tumor-derived factors Anticancer Res. 16 1996 3923 3929
25. D. Medina, and K.B. DeOme Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination J. Natl. Cancer Inst. 42 1969 303 310
26. M.H. Julius, E. Simpson, and L.A. Herzenberg A rapid method for the isolation of functional thymus-derived murine lymphocytes Eur. J. Immunol. 3 1973 645 649
27. S.L. Topalian, D. Solomon, and S.A. Rosenberg Tumor-specific cytolysis by lymphocytes infiltrating human melanomas J. Immunol. 142 1989 3714 3725
28. M.N. Ajuebor, A.M. Das, L. Virag, R.J. Flower, C. Szabo, and M. Perretti Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10 J. Immunol. 162 1999 1685 1691
29. H. Muta, L.H. Boise, L. Fang, and E.R. Podack CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis J. Immunol. 165 2000 5105 5111
30. C. Calderon, Z.H. Huang, D.A. Gage, E.M. Sotomayor, and D.M. Lopez Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine J. Exp. Med. 180 1994 945 958
31. E. Van Coillie, J. Van Damme, and G. Opdenakker The MCP/eotaxin subfamily of CC chemokines Cytokine Growth Factor Rev. 10 1999 61 86
32. J. Van Damme, P. Proost, W. Put, S. Arens, J.P. Lenaerts, R. Conings, G. Opdenakker, H. Heremans, and A. Billiau Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA J. Immunol. 152 1994 5495 5502
33. K.G. Steube, C. Meyer, and H.G. Drexler Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli Leuk. Res. 23 1999 843 849
34. M. Zaks-Zilberman, T.Z. Zaks, and S.N. Vogel Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines Cytokine 15 2001 156 165
35. S.C. Buessow, R.D. Paul, A.M. Miller, and D.M. Lopez Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocarcinoma. I. Characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity Int. J. Cancer 33 1984 79 85
36. J.L. Owen, V. Iragavarapu-Charyulu, Z. Gunja-Smith, L.M. Herbert, J.F. Grosso, and D.M. Lopez Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor J. Immunol. 171 2003 4340 4351
37. D.M. Lopez, M. Lopez-Cepero, G.A. Watson, A. Ganju, E. Sotomayor, and Y.X. Fu Modulation of the immune system by mammary tumor-derived factors Cancer Invest. 9 1991 643 653
38. Y.X. Fu, G. Watson, J.J. Jimenez, Y. Wang, and D.M. Lopez Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor Cancer Res. 50 1990 227 234
39. M. Lopez-Cepero, J.A. Garcia-Sanz, L. Herbert, R. Riley, M.E. Handel, E.R. Podack, and D.M. Lopez Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets J. Immunol. 152 1994 3333 3341
40. V.I. Charyulu, and D.M. Lopez Elevated GM-CSF levels in tumor bearing mice upregulate IL-6 production by B cells via a mechanism independent of TNF-alpha Int. J. Oncol. 16 2000 161 167
41. M.E. Handel-Fernandez, and D.M. Lopez Altered binding of the NF-GMa transcription factor is involved in the upregulated production of TNF-alpha by macrophages of mammary tumor bearing mice Int. J. Mol. Med. 1 1998 227 234
42. P. Biswas, F. Delfanti, S. Bernasconi, M. Mengozzi, M. Cota, N. Polentarutti, A. Mantovani, A. Lazzarin, S. Sozzani, and G. Poli Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line Blood 91 1998 258 265
43. H.J. Gruss, M.A. Brach, R.R. Schumann, and F. Herrmann Regulation of MCP-1/JE gene expression during monocytic differentiation J. Immunol. 153 1994 4907 4914
44. H. Shinohara, S. Yano, C.D. Bucana, and I.J. Fidler Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells J. Immunol. 164 2000 2728 2737
45. C. Zoja, J.M. Wang, S. Bettoni, M. Sironi, D. Renzi, F. Chiaffarino, H.E. Abboud, J. Van Damme, A. Mantovani, and G. Remuzzi Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells Am. J. Pathol. 138 1991 991 1003
46. K. Hayashida, T. Kitamura, D.M. Gorman, K. Arai, T. Yokota, and A. Miyajima Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor Proc. Natl. Acad Sci. USA 87 1990 9655 9659
47. A. al-Aoukaty, A. Giaid, C. Sinoff, A.D. Ho, and A.A. Maghazachi Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes Blood 83 1994 1299 1309
48. P.F. Vitiello, M.G. Shainheit, E.M. Allison, E.P. Adler, and R.A. Kurt Impact of tumor-derived CCL2 on T cell effector function Immunol. Lett. 91 2004 239 245
49. U. Boehm, T. Klamp, M. Groot, and J.C. Howard Cellular responses to interferon-gamma Annu. Rev. Immunol. 15 1997 749 795
50. X. Cheng, and D.M. Lopez CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma: role of phosphatidyl serine J. Immunol. 160 1998 2735 2741
51. D. Santoli, S.C. Clark, B.L. Kreider, P.A. Maslin, and G. Rovera Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor J. Immunol. 141 1988 519 526
52. M.J. Gilbreath, C.A. Nacy, D.L. Hoover, C.R. Alving, G.M. Swartz Jr., and M.S. Meltzer Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine- phosphatidylserine liposomes J. Immunol. 134 1985 3420 3425
53. Y. Aramaki, F. Nitta, R. Matsuno, Y. Morimura, and S. Tsuchiya Inhibitory effects of negatively charged liposomes on nitric oxide production from macrophages stimulated by LPS Biochem. Biophys. Res. Commun. 220 1996 1 6
54. M. Nesbit, H. Schaider, T.H. Miller, and M. Herlyn Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells J. Immunol. 166 2001 6483 6490
55. L. Gu, S. Tseng, R.M. Horner, C. Tam, M. Loda, and B.J. Rollins Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 Nature 404 2000 407 411
56. M.C. Braun, E. Lahey, and B.L. Kelsall Selective suppression of IL-12 production by chemoattractants J. Immunol. 164 2000 3009 3017
57. N. Omata, M. Yasutomi, A. Yamada, H. Iwasaki, M. Mayumi, and Y. Ohshima Monocyte chemoattractant protein-1 selectively inhibits the acquisition of CD40 ligand-dependent IL-12-producing capacity of monocyte-derived dendritic cells and modulates Th1 immune response J. Immunol. 169 2002 4861 4866